ArticleJournal for immunotherapy of cancer2026

Anti-PD1-IL18 immunoconjugate promotes effector T cell-mediated antitumor immunity.

Nicole Oelgarth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.